Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bondeson

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Annals of the Rheumatic Diseases|October 29, 2000
Adenoviral transgene delivery provides an approach to identifying important molecular processes in inflammation: evidence for heterogenecity in the requirement for NFkappaB in tumour necrosis factor productionB M Foxwell, J Bondeson, F Brennan, et al.
Acta Chirurgica Scandinavica|November 1, 1989
Perianal abscess and sinuses caused by granuloma inguinale. Case reportJ Bondeson, M Bohe, U Carlsson, et al.
Rheumatology (Oxford, England)|March 31, 2006
Adenoviral gene transfer into osteoarthritis synovial cells using the endogenous inhibitor IkappaBalpha reveals that most, but not all, inflammatory and destructive mediators are NFkappaB dependentN Amos, S Lauder, A Evans, et al.
Rheumatology (Oxford, England)|November 27, 2004
Reversible focal myositis in a patient taking venlafaxineD P A Jewell, I W Thompson, B A Sullivan, et al.
Transplantation Proceedings|May 30, 2001
Analysis of cytokine expression in rheumatoid synovium has provided new insights into the pathogenesis of rheumatoid arthritis and new therapeutic opportunitiesM Feldmann, F Brennan, J Bondeson, et al.
European Journal of Immunology|July 4, 2001
Role of NFkappaB in antigen presentation and development of regulatory T cells elucidated by treatment of dendritic cells with the proteasome inhibitor PSIS Yoshimura, J Bondeson, F M Brennan, et al.
International Immunology|April 20, 2001
Effective antigen presentation by dendritic cells is NF-kappaB dependent: coordinate regulation of MHC, co-stimulatory molecules and cytokinesS Yoshimura, J Bondeson, B M Foxwell, et al.
Annals of the Rheumatic Diseases|March 14, 2002
High efficiency gene transfer is an efficient way of defining therapeutic targets: a functional genomics approachB M Foxwell, S Yoshimura, J Bondeson, et al.
Annals of the Rheumatic Diseases|December 1, 1999
The rationale for the current boom in anti-TNFalpha treatment. Is there an effective means to define therapeutic targets for drugs that provide all the benefits of anti-TNFalpha and minimise hazards?M Feldmann, J Bondeson, F M Brennan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 1999
Selective regulation of cytokine induction by adenoviral gene transfer of IkappaBalpha into human macrophages: lipopolysaccharide-induced, but not zymosan-induced, proinflammatory cytokines are inhibited, but IL-10 is nuclear factor-kappaB independentJ Bondeson, K A Browne, F M Brennan, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Annals of the Rheumatic Diseases|October 29, 2000
Adenoviral transgene delivery provides an approach to identifying important molecular processes in inflammation: evidence for heterogenecity in the requirement for NFkappaB in tumour necrosis factor productionB M Foxwell, J Bondeson, F Brennan, et al.
Acta Chirurgica Scandinavica|November 1, 1989
Perianal abscess and sinuses caused by granuloma inguinale. Case reportJ Bondeson, M Bohe, U Carlsson, et al.
Rheumatology (Oxford, England)|March 31, 2006
Adenoviral gene transfer into osteoarthritis synovial cells using the endogenous inhibitor IkappaBalpha reveals that most, but not all, inflammatory and destructive mediators are NFkappaB dependentN Amos, S Lauder, A Evans, et al.
Rheumatology (Oxford, England)|November 27, 2004
Reversible focal myositis in a patient taking venlafaxineD P A Jewell, I W Thompson, B A Sullivan, et al.
Transplantation Proceedings|May 30, 2001
Analysis of cytokine expression in rheumatoid synovium has provided new insights into the pathogenesis of rheumatoid arthritis and new therapeutic opportunitiesM Feldmann, F Brennan, J Bondeson, et al.
European Journal of Immunology|July 4, 2001
Role of NFkappaB in antigen presentation and development of regulatory T cells elucidated by treatment of dendritic cells with the proteasome inhibitor PSIS Yoshimura, J Bondeson, F M Brennan, et al.
International Immunology|April 20, 2001
Effective antigen presentation by dendritic cells is NF-kappaB dependent: coordinate regulation of MHC, co-stimulatory molecules and cytokinesS Yoshimura, J Bondeson, B M Foxwell, et al.
Annals of the Rheumatic Diseases|March 14, 2002
High efficiency gene transfer is an efficient way of defining therapeutic targets: a functional genomics approachB M Foxwell, S Yoshimura, J Bondeson, et al.
Annals of the Rheumatic Diseases|December 1, 1999
The rationale for the current boom in anti-TNFalpha treatment. Is there an effective means to define therapeutic targets for drugs that provide all the benefits of anti-TNFalpha and minimise hazards?M Feldmann, J Bondeson, F M Brennan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 1999
Selective regulation of cytokine induction by adenoviral gene transfer of IkappaBalpha into human macrophages: lipopolysaccharide-induced, but not zymosan-induced, proinflammatory cytokines are inhibited, but IL-10 is nuclear factor-kappaB independentJ Bondeson, K A Browne, F M Brennan, et al.
Pageof 7